Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Martin Marietta Materials
MLM
$32.7B
| $413K | ﹤0.01% |
1,894
-208,400
| -99% | -$46M |
|
|
PER
2827
DELISTED
SANDRIDGE PERMIAN TRUST
PER
| $413K | ﹤0.01% |
142,322
-259,670
| -65% | -$828K |
|
2828
Cerus
CERS
$546M
| $412K | ﹤0.01% |
92,500
+10,500
| +13% | +$44.5K |
|
|
BVSN
2829
DELISTED
Broadvision Inc Com
BVSN
| $410K | ﹤0.01% |
80,600
+2,000
| +3% | +$10.6K |
|
2830
Arbutus Biopharma
ABUS
$907M
| $405K | ﹤0.01% |
124,573
+110,499
| +785% | +$307K |
|
|
CCRC
2831
DELISTED
China Customer Relations Centers, Inc
CCRC
| $403K | ﹤0.01% |
29,554
+4,954
| +20% | +$73.9K |
|
2832
Daxor
DXR
$59.5M
| $402K | ﹤0.01% |
54,300
| – | – |
|
2833
Hormel Foods
HRL
$13.4B
| $402K | ﹤0.01% |
11,600
-933,295
| -99% | -$33.3M |
|
2834
Genasys
GNSS
$77.4M
| $400K | ﹤0.01% |
265,000
-20,400
| -7% | -$32.8K |
|
|
CYAN
2835
DELISTED
Cyanotech Corp
CYAN
| $399K | ﹤0.01% |
103,600
+2,700
| +3% | +$11K |
|
2836
Imunon
IMNN
$6.77M
| $397K | ﹤0.01% |
502
+252
| +101% | +$217K |
|
2837
Lloyds Banking Group
LYG
$89.8B
| $396K | ﹤0.01% |
116,500
-3,981,701
| -97% | -$13.4M |
|
2838
Monolithic Power Systems
MPWR
$70B
| $396K | ﹤0.01% |
4,300
-52,800
| -92% | -$4.68M |
|
2839
Novavax
NVAX
$1.31B
| $395K | ﹤0.01% |
15,443
-6,128
| -28% | -$169K |
|
|
NWHM
2840
DELISTED
THE NEW HOME COMPANY INC.
NWHM
| $395K | ﹤0.01% |
37,800
+17,500
| +86% | +$189K |
|
|
USAK
2841
DELISTED
USA Truck Inc
USAK
| $392K | ﹤0.01% |
53,400
-103,200
| -66% | -$912K |
|
|
MICR
2842
DELISTED
Micron Solutions, Inc.
MICR
| $391K | ﹤0.01% |
97,200
+2,500
| +3% | +$10.2K |
|
2843
Veru
VERU
$46.7M
| $390K | ﹤0.01% |
38,570
-5,380
| -12% | -$55.7K |
|
2844
LGL Group
LGL
$93.3M
| $389K | ﹤0.01% |
202,878
+7,956
| +4% | +$14.7K |
|
2845
Viking Therapeutics
VKTX
$3.97B
| $388K | ﹤0.01% |
265,800
+102,600
| +63% | +$143K |
|
2846
Mind CTI
MNDO
$20.6M
| $387K | ﹤0.01% |
159,281
+39,381
| +33% | +$101K |
|
|
TSRI
2847
DELISTED
TSR Inc. New
TSRI
| $380K | ﹤0.01% |
66,650
-18,700
| -22% | -$102K |
|
|
RELV
2848
DELISTED
Reliv International Inc
RELV
| $378K | ﹤0.01% |
70,980
+800
| +1% | +$4.03K |
|
|
TCS
2849
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $375K | ﹤0.01% |
5,913
-20,640
| -78% | -$1.43M |
|
2850
B&G Foods
BGS
$291M
| $374K | ﹤0.01% |
9,300
-229,600
| -96% | -$9.98M |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.